Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Global Regulatory Systems01:28

Global Regulatory Systems

29
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TPP-45142-an Anti-HER2 T-cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy.

Molecular cancer therapeutics·2026
Same author

Identification and Nonclinical Characterization of SAR444200, a Novel Anti-GPC3 NANOBODY T-cell Engager, for the Treatment of GPC3+ Solid Tumors.

Molecular cancer therapeutics·2025
Same author

Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.

Nature·2022
Same author

A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells.

Nature·2022
Same author

Erratum to: Two ubiquitin-associated ER proteins interact with COPT copper transporters and modulate their accumulation.

Plant physiology·2021
Same author

Two ubiquitin-associated ER proteins interact with COPT copper transporters and modulate their accumulation.

Plant physiology·2021

Related Experiment Video

Updated: Jul 13, 2025

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

20.5K

RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function.

Alyssa L Flynn1, Joseph Gans2, Javier Escobedo2

  • 1Department of Oncology, Sanofi, Cambridge, MA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 18, 2023
PubMed
Summary

The novel regulator RGS1 controls regulatory T cells (Tregs) and their immunosuppressive function. RGS1 deficiency impairs Treg function, offering a potential therapeutic target for cancer and autoimmune diseases.

More Related Videos

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

7.3K
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

331

Related Experiment Videos

Last Updated: Jul 13, 2025

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

20.5K
siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

7.3K
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

331

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Regulatory T cells (Tregs) are crucial for immune tolerance but are implicated in cancer immunosuppression and autoimmunity.
  • Dysregulation of Tregs can lead to a loss of self-tolerance, resulting in autoimmune conditions.
  • The precise molecular mechanisms governing Treg function remain an active area of research.

Purpose of the Study:

  • To identify novel regulators of regulatory T cell (Treg) function.
  • To investigate the role of GTPase activator regulator of G protein 1 (RGS1) in Treg biology.
  • To explore the therapeutic potential of targeting RGS1 in immune-related diseases.

Main Methods:

  • Analysis of RGS1-deficient human Tregs.
  • Gene expression profiling to identify Treg-associated genes.
  • Assessment of Treg immunosuppressive capacity and metabolic profiles.

Main Results:

  • RGS1-deficient Tregs exhibit downregulated Treg-associated genes and reduced immunosuppressive function.
  • Perturbations in the FOXP3-c-MYC transcriptional axis were observed in RGS1-deficient Tregs.
  • These Tregs showed a metabolic shift towards glycolysis and decreased autophagy.

Conclusions:

  • RGS1 acts as a novel regulator of Treg function, potentially through the FOXP3-c-MYC transcriptional axis.
  • RGS1 influences Treg metabolism and autophagy.
  • Targeting RGS1 presents a potential therapeutic strategy for cancer and autoimmune diseases.